T1	Procedure 4 35	allogeneic stem cell transplant
T2	Value 46 56	= 14 years
T3	Person 60 63	age
T4	Value 68 78	= 60 years
T5	Person 82 85	age
R1	Has_value Arg1:T5 Arg2:T4	
R2	Has_value Arg1:T3 Arg2:T2	
T6	Measurement 87 96	Bilirubin
T7	Measurement 98 102	SGOT
T8	Measurement 103 107	SGPT
T9	Value 108 133	< 5 × upper normal limits
R3	Has_value Arg1:T8 Arg2:T9	
R4	Has_value Arg1:T7 Arg2:T9	
R5	Has_value Arg1:T6 Arg2:T9	
T10	Measurement 136 146	Creatinine
T11	Value 147 172	< 2 × upper normal limits
R6	Has_value Arg1:T10 Arg2:T11	
T12	Measurement 175 192	Ejection fraction
T13	Value 193 198	= 50%
T14	Negation 200 202	no
T15	Qualifier 203 209	severe
T16	Condition 210 220	arrhythmia
R7	Has_qualifier Arg1:T16 Arg2:T15	
R8	Has_negation Arg1:T16 Arg2:T14	
R9	Has_value Arg1:T12 Arg2:T13	
*	OR T12 T16
T17	Observation 223 248	Estimated life expectancy
T18	Value 249 259	= 6 months
R10	Has_value Arg1:T17 Arg2:T18	
T19	Measurement 272 279	CMV-DNA
T20	Value 280 291	= 1000cp/ml
T21	Person 295 310	treatment group
T22	Person 333 351	prophylactic group
T23	Value 321 329	negative
A1	Optional T21
A2	Optional T22
R11	Has_value Arg1:T22 Arg2:T23	
R12	Has_value Arg1:T21 Arg2:T20	
*	OR T21 T22
T24	Scope 280 351	= 1000cp/ml in treatment group and being negative in prophylactic group
R13	Has_scope Arg1:T19 Arg2:T24	
